Questions a plan sponsor actually asks.
What is Relugolix, Estradiol Hemihydrate, and Norethindrone used for?
Relugolix, Estradiol Hemihydrate, and Norethindrone is a Gonadotropin Releasing Hormone Receptor Antagonist medication tracked in Medicare Part D.
Is there a generic for Relugolix, Estradiol Hemihydrate, and Norethindrone?
No. Relugolix, Estradiol Hemihydrate, and Norethindrone is brand-only with no generic equivalents currently in market.
How much does my plan pay for Relugolix, Estradiol Hemihydrate, and Norethindrone?
Across 329 Part D plans, Relugolix, Estradiol Hemihydrate, and Norethindrone averages $45.36/unit (NADAC). Lowest available: $45.36/unit. Highest in distribution: $45.36/unit.
Is Relugolix, Estradiol Hemihydrate, and Norethindrone on the FDA shortage list?
No. Relugolix, Estradiol Hemihydrate, and Norethindrone is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.